TROP2 expression in head and neck squamous cell carcinoma: association with the tumor immune microenvironment and clinical outcome
Introduction TROP2 is a transmembrane glycoprotein implicated in tumor progression and immune regulation across epithelial malignancies and serves as a therapeutic target for antibody -drug conjugates. Its role in the tumor immune microenvironment of head and neck squamous cell carcinoma (HNSCC), particularly in the co...